UBCS039

UBCS039
	File:UBCS039 structure.png
臨床資料
藥物類別	Sirtuin-6 (SIRT6) activator
識別資訊
	IUPAC命名法 4-pyridin-3-yl-4,5-dihydropyrrolo[1,2-a]quinoxaline; ;
CAS號	358721-70-7
PubChem CID	2803797;
E編碼	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Module:EditAtWikidata第29行Lua錯誤：attempt to index field 'wikibase' (a nil value);
ECHA InfoCard	{{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤：attempt to index field 'wikibase' (a nil value)
化學資訊
化學式	C16H13N3
摩爾質量	247.30 g·mol−1
3D模型（JSmol）	交互式圖像;
	SMILES C1=CC=C2C(=C1)NC(C3=CC=CN32)C4=CN=CC=C4;
	InChI InChI=1S/C16H13N3/c1-2-7-14-13(6-1)18-16(12-5-3-9-17-11-12)15-8-4-10-19(14)15/h1-11,16,18H; Key:BSOBGTYXYGHUTD-UHFFFAOYSA-N;

參考文獻[編輯]

^ Wang D, Zhou Y, Yang N, Liu J, Lu L, Gao Z. SIRT6 mitigates acute kidney injury by enhancing lipid metabolism and reducing tubular epithelial cell apoptosis via suppression of the ACMSD signaling pathway. Cellular Signalling. July 2025, 131. PMID 40120964. doi:10.1016/j.cellsig.2025.111757. 已忽略未知參數|article-number= (幫助)
^ Sinha R, Singh P, Zeng H, Kumar A, Antony VB. Cadmium exposure triggers vimentin phosphorylation via SIRT6-regulated AKT/PI3K signaling pathway in COPD. European Journal of Cell Biology. September 2025, 104 (3). PMID 40609497. doi:10.1016/j.ejcb.2025.151503. 已忽略未知參數|article-number= (幫助)